Literature DB >> 26388243

Universal Neonatal Hearing Screening Program in Poland--10-year summary.

Grażyna Greczka1, Maciej Wróbel1, Piotr Dąbrowski1, Katarzyna Mikołajczak1, Witold Szyfter1.   

Abstract

INTRODUCTION: The analysis was aimed to summarize the outcomes of Polish Universal Neonatal Hearing Screening Program (PUNHSP).
MATERIALS AND METHODS: The analysis comprised the population of children registered in the PUNHSP database between 2003 and 2013. The evaluated parameters included: the program coverage (percentage of children covered by the Program in relation to the number of births), results of screening tests at different levels of the Program and hearing loss incidence.
RESULTS: The average screened population was 96,0% with respect to total number of live births in Poland. Children requiring further evaluation represent annual average 8.5% of the study population. Among them, on average 55.8% were consulted in audiological centers. Hearing loss incidence was estimated to be 0,3%. The highest hearing loss incidence was detected in children which failed the OAE test with concomitant risk factors. 58.2% of children were fitted with hearing aids, 34.0% were referred for surgical treatment, and 7.8% for further rehabilitation.
CONCLUSIONS: The results of the program evaluation confirmed its good efficiency. The coverage and hearing tests results are comparable to those from other countries conducting similar national hearing screening programs.

Entities:  

Mesh:

Year:  2015        PMID: 26388243     DOI: 10.5604/00306657.1156325

Source DB:  PubMed          Journal:  Otolaryngol Pol        ISSN: 0030-6657


  2 in total

1.  Newborn hearing loss in the south of China: a cross-sectional study.

Authors:  Yuanming Wang; Chen Cheng; Chuling Li
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

2.  Newborn hearing screening coverage and detection rates of hearing impairment across China from 2008-2016.

Authors:  Xuelian Yuan; Kui Deng; Jun Zhu; Liangcheng Xiang; Yongna Yao; Qi Li; Xiaohong Li; Hanmin Liu
Journal:  BMC Pediatr       Date:  2020-07-30       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.